Abstract 5060: Role of molecular driver mutations in recurrence of early stage laryngeal cancer following narrow field definitive radiotherapy

Aaron Segura(University of New Mexico), Andrés M. Bur(University of Kansas), Rohit Nallani(University of Kansas Medical Center), Deri Morgan(University of Kansas Medical Center), Kiran Kakarala(University of Kansas Medical Center), R. Morse(University of North Carolina at Chapel Hill), Devin C. Koestler(University of Kansas Medical Center), Umamaheswar Duvvuri(City University of New York), Kevin J. Sykes(University of Kansas Medical Center), Sufi M. Thomas(University of New Mexico), Emrullah Yilmaz(Cleveland Clinic), Emily Nissen(University of Kansas Medical Center), Randall J. Kimple(University of Wisconsin–Madison), Chris Lominska(The University of Kansas Cancer Center), Dong Pei(Sun Yat-sen University), Prakash Neupane(University of Kansas Medical Center), Lisa Shnayder(University of Kansas Medical Center)
Cancer Research
March 22, 2024
10.1158/1538-7445.am2024-5060
Cited by 0

Related Papers

Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
|Immunity|2020|688
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
|Cancer Discovery|2013|590
Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay
|Cancer|2014|502
Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology
|Thyroid|2015|393
B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma
|Nature Communications|2021|365